Link to this page
Medical Subject Headings
Last uploaded:
January 16, 2025
Jump to:
| Preferred Name | siponimod | |
| Synonyms |
1-(4-(1-((E)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino)-ethyl)-2-ethylbenzyl)-azetidine-3-carboxylic acid Mayzent BAF312 BAF-312 |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C578989 |
|
| altLabel |
1-(4-(1-((E)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino)-ethyl)-2-ethylbenzyl)-azetidine-3-carboxylic acid Mayzent BAF312 BAF-312
|
|
| cui |
C4548896 C3657824 C4764790
|
|
| HM |
D001593 D001384
|
|
| II |
D049349/Q000037
|
|
| Inverse of RB |
RR6P8L282I
|
|
| isa | ||
| LT |
TRD
|
|
| Mapped to | ||
| MDA |
20130318
|
|
| MeSH Frequency |
113
|
|
| MMR |
20190617
|
|
| notation |
C578989
|
|
| PA |
D000081243
|
|
| prefLabel |
siponimod
|
|
| SC |
1
|
|
| Scope Statement |
S1P receptor modulator
|
|
| SRC |
Br J Pharmacol. 2012 Nov;167(5):1035-47
|
|
| TERMUI |
T000931585 T000903355 T838814 T000953976 T838904
|
|
| TH |
NLM (2016) FDA SRS (2017) NLM (2019) USAN (19XX) INN (19XX) NLM (2013) NLM (2017)
|
|
| tui |
T109 T129 T121
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping